PA
NUTX

Parallel Advisors’s Nutex Health NUTX Stock Holding History

Parallel Advisors’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95 Buy
+1
New +$123 ﹤0.01% 3785

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

Parallel Advisors's NUTX Position: Q1 2026 in Review

Parallel Advisors opened a new position in Nutex Health (NUTX) in Q1 2026: 1 share worth $95. The stake represents ﹤0.01% of the portfolio and ranks #3785 among its holdings.

129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Parallel Advisors held 1 share of Nutex Health worth $95 as of Q1 2026.
  • Nutex Health was a new Parallel Advisors position in Q1 2026.
  • Nutex Health made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #3785 holding.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.